| Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion F Voli, E Valli, L Lerra, K Kimpton, F Saletta, FM Giorgi, D Mercatelli, ... Cancer research 80 (19), 4129-4144, 2020 | 209 | 2020 |
| Copper: an intracellular achilles’ heel allowing the targeting of epigenetics, kinase pathways, and cell metabolism in cancer therapeutics F Michniewicz, F Saletta, JRC Rouaen, RV Hewavisenti, D Mercatelli, ... ChemMedChem 16 (15), 2315-2329, 2021 | 52 | 2021 |
| Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG A Ehteda, S Simon, L Franshaw, FM Giorgi, J Liu, S Joshi, JRC Rouaen, ... Cell reports 35 (2), 2021 | 29 | 2021 |
| Natural polysaccharide carriers in brain delivery: challenge and perspective M Curcio, G Cirillo, JRC Rouaen, F Saletta, FP Nicoletta, O Vittorio, ... Pharmaceutics 12 (12), 1183, 2020 | 21 | 2020 |
| Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer EM Poursani, D Mercatelli, P Raninga, JL Bell, F Saletta, FV Kohane, ... Cell & Bioscience 13 (1), 132, 2023 | 3 | 2023 |
| Copper chelation inhibits TGF-β pathways and suppresses epithelial-mesenchymal transition in cancer EM Poursani, D Mercatelli, P Raninga, JL Bell, F Saletta, FV Kohane, ... biorxiv, 2022.10. 03.510707, 2022 | 1 | 2022 |
| Copper chelation overcomes the immunosuppressive tumor microenvironment in neuroblastoma JR Rouaen, D Mercatelli, F Saletta, EM Poursani, JE Murray, N Tedla, ... Cancer Research 82 (12_Supplement), 5214-5214, 2022 | 1 | 2022 |
| Priming of the glioblastoma tumour microenvironment via copper chelation to enhance the efficacy of immunotherapies T Shai-Hee, TR Jue, R Cazzoli, JR Rouaen, F Michniewicz, J Bell, ... Cancer Research 84 (6_Supplement), 1418-1418, 2024 | | 2024 |
| A comprehensive approach: Copper chelation therapy modulates epigenetic, kinase signaling and metabolic pathways in diffuse midline gliomas (DMG) F Michniewicz, R Cazzoli, J Bell, F Saletta, E Poursani, JR Rouaen, ... Cancer Research 84 (6_Supplement), 525-525, 2024 | | 2024 |
| Copper chelation overcomes the immunosuppressive neuroblastoma microenvironment to potentiate anti-GD2 antibody therapy JR Rouaen, A Salerno, F Luciani, J Murray, T Shai-Hee, N Tedla, ... Cancer Research 84 (6_Supplement), 2673-2673, 2024 | | 2024 |
| Copper chelation overcomes the immunosuppressive neuroblastoma tumour microenvironment to enhance anti-GD2 immunotherapy J Rouaen UNSW Sydney, 2024 | | 2024 |
| Near-Infrared Ratiometric Fluorescent Probe for Detecting Endogenous Cu2+ in the Brain J Zhu, ME Graziotto, V Cottam, T Hawtrey, LD Adair, BG Trist, NTH Pham, ... ACS sensors, 2023 | | 2023 |
| DIPG-06. Uncovering the FACTs in Diffuse Midline Glioma (DMG) H Holliday, A Ehteda, A Khan, B Krug, JRC Rouaen, N Jayatilleke, ... Neuro-Oncology 24 (Suppl 1), i18, 2022 | | 2022 |
| HGG-09. TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION IN DIPG A Ehteda, S Simon, L Franshaw, FM Giorgi, J Liu, E Hayden, J Rouaen, ... Neuro-oncology 23 (Supplement_1), i18-i19, 2021 | | 2021 |
| Dual Targeting of the Epigenome Via Facilitates Chromatin Transcription Complex (FACT) and Histone Deacetylase is a Potent Treatment Strategy for DIPG A Ehteda, S Simon, L Franshaw, FM Giorgi, J Liu, E Hayden, S Joshi, ... | | |
